Consun Pharma Repurchases 127,000 Shares for HKD 1.80 Million, Outstanding Share Count Falls to 840.76 Million

Bulletin Express06-03

Consun Pharmaceutical Group Limited reported a new share buyback executed on 03 June 2026. The company repurchased 127,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 14.02 to HKD 14.39, for an aggregate consideration of HKD 1.80 million. The volume-weighted average repurchase price was HKD 14.20 per share.

Following the transaction, issued shares (excluding treasury stock) decreased from 840.89 million to 840.76 million, a reduction of 0.0151%. Treasury shares rose to 789,000, while the total issued share capital (including treasury shares) remained unchanged at 841.55 million.

The buyback forms part of the mandate approved on 26 May 2026, which authorises the repurchase of up to 84.12 million shares. To date, 445,000 shares—equivalent to 0.529% of the issued share base on the mandate date—have been repurchased under this authority. Under Hong Kong listing rules, a moratorium on new share issues or treasury share sales is in place until 03 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1132514450?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-03 20:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1132514450","market":"us","top_or_hot":-1,"title":"Consun Pharma Repurchases 127,000 Shares for HKD 1.80 Million, Outstanding Share Count Falls to 840.76 Million","media":"Bulletin Express","content":"<p>Consun Pharmaceutical Group Limited reported a new share buyback executed on 03 June 2026. The company repurchased 127,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 14.02 to HKD 14.39, for an aggregate consideration of HKD 1.80 million. The volume-weighted average repurchase price was HKD 14.20 per share.</p>\n<p>Following the transaction, issued shares (excluding treasury stock) decreased from 840.89 million to 840.76 million, a reduction of 0.0151%. Treasury shares rose to 789,000, while the total issued share capital (including treasury shares) remained unchanged at 841.55 million.</p>\n<p>The buyback forms part of the mandate approved on 26 May 2026, which authorises the repurchase of up to 84.12 million shares. To date, 445,000 shares—equivalent to 0.529% of the issued share base on the mandate date—have been repurchased under this authority. Under Hong Kong listing rules, a moratorium on new share issues or treasury share sales is in place until 03 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Consun Pharma Repurchases 127,000 Shares for HKD 1.80 Million, Outstanding Share Count Falls to 840.76 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConsun Pharma Repurchases 127,000 Shares for HKD 1.80 Million, Outstanding Share Count Falls to 840.76 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-03 20:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Consun Pharmaceutical Group Limited reported a new share buyback executed on 03 June 2026. The company repurchased 127,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 14.02 to HKD 14.39, for an aggregate consideration of HKD 1.80 million. The volume-weighted average repurchase price was HKD 14.20 per share.</p>\n<p>Following the transaction, issued shares (excluding treasury stock) decreased from 840.89 million to 840.76 million, a reduction of 0.0151%. Treasury shares rose to 789,000, while the total issued share capital (including treasury shares) remained unchanged at 841.55 million.</p>\n<p>The buyback forms part of the mandate approved on 26 May 2026, which authorises the repurchase of up to 84.12 million shares. To date, 445,000 shares—equivalent to 0.529% of the issued share base on the mandate date—have been repurchased under this authority. Under Hong Kong listing rules, a moratorium on new share issues or treasury share sales is in place until 03 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01681","symbol_name":"康臣药业","start_time":0,"source_url":"","article_id":"1132514450","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1132514450","pubTimestamp":1780488200,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Consun Pharmaceutical Group Limited reported a new share buyback executed on 03 June 2026. The company repurchased 127,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01681":"康臣药业"},"translate_title":"康臣药业180万港元回购12.7万股流通股数降至8.4076亿股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01681":1},"content_text":"Consun Pharmaceutical Group Limited reported a new share buyback executed on 03 June 2026. The company repurchased 127,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 14.02 to HKD 14.39, for an aggregate consideration of HKD 1.80 million. The volume-weighted average repurchase price was HKD 14.20 per share.\nFollowing the transaction, issued shares (excluding treasury stock) decreased from 840.89 million to 840.76 million, a reduction of 0.0151%. Treasury shares rose to 789,000, while the total issued share capital (including treasury shares) remained unchanged at 841.55 million.\nThe buyback forms part of the mandate approved on 26 May 2026, which authorises the repurchase of up to 84.12 million shares. To date, 445,000 shares—equivalent to 0.529% of the issued share base on the mandate date—have been repurchased under this authority. Under Hong Kong listing rules, a moratorium on new share issues or treasury share sales is in place until 03 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1132514450","isCrawlerRequest":true}